Gastrinoma in Multiple Endocrine Neoplasia Type 1

References

• Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am J Med 1954; 16: 363–71
   PubMed Web of Science ®Google Scholar
• Lamers C BH. Multiple endocrine neoplasia type I (Wermer's syndrome). Neth J Med 1978; 21: 270–4
   PubMed Web of Science ®Google Scholar
• Modlin I M, Lamers C BH. Multiple endocrine neoplasia; Wermer's syndrome. S Afr Med J 1979; 56: 485–8
   PubMedGoogle Scholar
• Öberg K, Skogseid B, Eriksson B. Multiple endocrine neoplasia type I (MEN I) Clinical, biochemical and genetical investigations. Acta Oncol 1989; 28: 383–8
   PubMed Web of Science ®Google Scholar
• Maton P N, Norton J A, Nieman L K, Doppman J L, Jensen RT. Multiple endocrine neoplasia type II with Zollinger-Ellison syndrome caused by a solitary pancreatic gastrinoma. JAMA 1989; 262: 535–7
   PubMed Web of Science ®Google Scholar
• Zollinger R M, Ellison EH. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg 1955; 142: 709–23
   PubMed Web of Science ®Google Scholar
• Lamers C B, Stadil F, van Tongeren JH. Prevalence of endocrine abnormalities in patients with the Zollinger-Ellison syndrome and in their families. Am J Med 1978; 64: 607–12
   PubMed Web of Science ®Google Scholar
• Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold MC. Multiple endocrine neoplasia type I gene maps to chromosome 11 and is lost in insulinoma. Nature 1988; 332: 85–7
   PubMed Web of Science ®Google Scholar
• Thakker R V, Bouloux P, Wooding C, et al. Association of parathyroid tumors in multiple endocrine neoplasia type I with loss of alleles on chromosome 11. N Engl J Med 1989; 321: 218–24
   PubMed Web of Science ®Google Scholar
• Watson R G, Johnston C F, O'Hare M MT, et al. The frequency of gastrointestinal endocrine tumours in a well-defined population in Northern Ireland 1970–1985. Quart J Med 1989; 267: 646–57
   Google Scholar
• Vasen H FA, Lamers C BHW, Lips C JM. Screening for the multiple endocrine neoplasia syndrome type I. Arch Intern Med 1989; 149: 2717–22
   PubMed Web of Science ®Google Scholar
• Lamers C BHW, Lind T, Moberg S, Jansen J BMJ, Olbe L. Omeprazole in Zollinger-Ellison syndrome: effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists. N Engl J Med 1984; 310: 758–62
   PubMed Web of Science ®Google Scholar
• Lloyd-Davies K A, Rutgersson K, Sölvell L. Omeprazole in the treatment of Zollinger-Ellison syndrome: a 4-year international study. Aliment Pharmacol 1988; 2: 13–32
   PubMedGoogle Scholar
• Pipeleers-Marichal M, Somers G, Willems G, et al. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type I and the Zollinger-Ellison syndrome. N Engl J Med 1990; 322: 723–7
   PubMed Web of Science ®Google Scholar
• Bhagawan B S, Slavin R E, Goldberg J, Rao RN. Ectopic gastrinoma and Zollinger-Ellison syndrome. Hum Pathol 1986; 17: 584–92
   PubMed Web of Science ®Google Scholar
• Maton P N, Gardner J D, Jensen RT. Cushing's syndrome in patients with the Zollinger-Ellison syndrome. N Engl J Med 1986; 315: 1–5
   PubMed Web of Science ®Google Scholar
• Lamers C BH, Diemel J M, Roeffen W. Levels of pancreatic polypeptide in Zollinger-Ellison syndrome and hyperparathyroidism from families with multiple endocrine adenomatosis type I. Digestion 1978; 18: 297–302
   PubMed Web of Science ®Google Scholar
• Lamers C BH, Hackeng W HL, Thien Th., van Tongeren J HM. Serum concentrations of immunoreactive calcitonin in patients with hypergastrinaemia. Digestion 1980; 20: 379–82
   PubMed Web of Science ®Google Scholar
• Solcia E, Capella C, Fiocca R, Rindi G, Rosai J. Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type I multiple endocrine neoplasia: a newly recognized association. Am J Surg Pathol 1990; 14: 503–13
   PubMed Web of Science ®Google Scholar
• Friesen SR. The development of endocrinopathies in the prospective screening of two families with multiple endocrine adenopathy, type I. World J Surg 1979; 3: 753–64
   PubMedGoogle Scholar
• Lamers C BHW, Rotter J I, Jansen J BMJ. Gastrin cell function in familial multiple endocrine neoplasia type I. Gut 1988; 29: 1358–63
   PubMed Web of Science ®Google Scholar
• Frucht H, Howard J M, Stark H A, et al. Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome. Am J Med 1989; 87: 528–36
   PubMed Web of Science ®Google Scholar
• Lamers C BHW, Rotter J I, Jansen J BMJ, Samloff IM. Serum pepsinogen I in familial multiple endocrine neoplasia type I. Dig Dis Sci 1988; 33: 1274–6
   PubMed Web of Science ®Google Scholar
• Lamers CB. Clinical usefulness of the secretin provocation test. J Clin Gastroent 1981; 3: 255–9
   PubMed Web of Science ®Google Scholar
• Jansen J BMJ, Lamers C BHW. Effect of changes in serum calcium on secretin-stimulated serum gastrin in patients with Zollinger-Ellison syndrome. Gastroenterology 1982; 83: 172–8
   Web of Science ®Google Scholar
• Sheppard B C, Norton J A, Doppman J L, Maton P N, Gardner J D, Jensen RT. Management of islet cell tumors in patients with multiple endocrine neoplasia: a prospective study. Surgery 1989; 106: 1108–18
   PubMed Web of Science ®Google Scholar
• Thompson N W, Bondeson A-G, Bondeson L, Vinik A. The surgical treatment of gastrinoma in MEN I syndrome patients. Surgery 1989; 106: 1081–6
   PubMed Web of Science ®Google Scholar
• Tisell L-E, Ahlman H. Treatment of the pancreatic disease of multiple endocrine neoplasia type 1 (MEN 1). Acta Oncol 1989; 28: 415–7
   PubMed Web of Science ®Google Scholar
• Richardson C T, Peters M N, Feldman M, et al. Treatment of Zollinger-Ellison syndrome with exploratory laparotomy, proximal gastric vagotomy, and H2-receptor antagonists. Gastroenterology 1985; 89: 357–67
   PubMed Web of Science ®Google Scholar
• Norton J A, Cornelius M J, Doppman J L, Maton P N, Gardner J D, Jensen RT. Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study. Surgery 1987; 102: 958–66
   PubMed Web of Science ®Google Scholar
• Jensen R T, Maton P N, Gardner JD. Current management of Zollinger-Ellison syndrome. Drugs 1986; 32: 188–96
   PubMed Web of Science ®Google Scholar
• Vinik A I, Moattari A R, Cho K., Thompson N. Transhepatic portal vein catheterization for localization of sporadic and MEN gastrinomas: a ten-year experience. Surgery 1990; 107: 246–55
   PubMed Web of Science ®Google Scholar
• von Schrenck T, Howard J M, Doppman J L, et al. Prospective study of chemotherapy in patients with metastatic gastrinoma. Gastroenterology 1988; 94: 1326–34
   PubMed Web of Science ®Google Scholar
• Öberg K, Eriksson B. Medical treatment of neuroendocrine gut and pancreatic tumors. Acta Oncol 1989; 28: 425–31
   PubMed Web of Science ®Google Scholar
• Lamers C BHW. Recent advances in diagnosis and treatment of pancreatic endocrine tumors. Current topics in gastroenterology and hepatology, G NJ Tijtigat, M van Blankenstein. Georg Thieme Verlag, Stuttgart-New York 1990; 442–7
   Google Scholar